Relationship between plasma BNP levels and left ventricular diastolic function as measured by radionuclide ventriculography in patients with coronary artery disease

Nuclear Medicine Review

Volumn 7, Issue 2, 2004, Pages 123-128

  Celiński, Rafal ^a,b   Cholewiński, Witold ^a   Stefaniak, Bogusław ^a   Tarkowska, Anna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b NONE   (Poland)

Author keywords

BNP; CAD; LV diastolic function; Radionuclide ventriculography

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RADIOISOTOPE VENTRICULOGRAPHY;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RADIONUCLIDE VENTRICULOGRAPHY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 12344250706     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Adam WE, Clausen M, Hellwig D, Henze E, Bitter F. Radionuclide ventriculography (equilibrium gated blood pool scaning) - its present clinical position and recent developments. Eur J Nucl Med 1988; 13: 637-647.
2. Adam WE, Tarkowska A, Bitter F, Stauch M, Geffers H. Equilibrium (gated) radionuclid ventriculography. Cardiovasc Radiol 1979; 2: 161-173.
3. Tarkowska A. Wentrykulografia radioizotopowa przy jednorodnym rozmieszczeniu substancji promieniotwórczej we krwi. Pol Przeg Rad 1983; 3: 253-257.
4. Maniu CV, Redfield MM. Diastolic dysfunction: insights into pathophysiology and pharmacotherapy. Expert Opin Pharmacother 2001; 2: 997-1008.
5. Perrone-Filardi P, Bacharach SL, Dilsizian V, Bonow RO. Impaired left ventricular filling and regional diastolic asynchrony at rest in coronary artery disease and relation to exercise - induced myocardial ischemia. Am J Cardiol 1991; 67: 356-360.
6. Narita M, Kurihara T, Murano K, Usami M, Kameoka M. Left ventricular diastolic filling in elder patients with systemic hypertension. Nippon Ronen Igakkai Zasshi. 1990; 27: 463-468.
7. Imai S, Kanda H, Suzuki T, Murata K. Analysis of the left ventricular early diastolic function in old myocardial infarction by gated radionuclide angiography. Jpn Circ J 1985; 47: 672-678.
8. Kaliuzhin W, Tepliakov AT, Solovstov MA. Role of left ventricular systolic and diastolic dysfunction in clinical manifestations of chronic heart failure in patients with prior myocardial infarction. Ter Arkh 2002; 74: 15-18.
9. Marzilli M. Systolic and diastolic alterations of left ventricular function: prevelance in ischaemic heart disease and importanc in the management of indyvidual patients. Eur Heart J 1988; 9 Suppl F: 1-4.
10. Kikuta K, Yasue H, Yoshimura M et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J 1996; 132: 101-107.
11. Yamada Y, Goto J, Yokoto M. Brain natriuretic peptide is a sensitive indicator of impaired left - ventricular function in elderly patients with cardiovascular disease. Cardiology 1997; 88: 401-407.
12. McCullough PA, Omland T, Maisel AS. B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 2003; 4: 72-80.
13. Doggrell SA. Brain natriuretic peptide: Disease marker or more in cardiovascular medicine? Drugs Today 2001; 37: 463-476.
14. Clerico A, Lervasi G, Del Chicca MG et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) neasured by highly sensitive and specific immunoradiometric assays in normal subject and in patients with different degrees of heart failure. J Endocrinol Ivest 1998; 21: 170-171.
15. Arad M, Elazar E, Shotan A, Klein R, Rabinowitz B. Brain and atrial natriuretic peptides with ischemic heart disease with and with out heart failure. Cardiology 1996; 87: 12-17.
16. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease. Data from the heart and soul study. Circulation 2003; 108: 2987-2992.
17. Davison NC, Naas AA, Hanson JK, Kennedy NSJ, Coutie WJ, Struthers AD. Comparison of Atrial natriuretic Peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 1996; 77: 828-831.
18. Deo R, de Lemos JA. B-type natriuretic peptide in ischemic heart disease. Curr Cardiol Rep 2003; 5: 271-277.
19. Goetze JP, Christoffersen C, Perko M et al. Increased czrdiac BNP expression associated with myocardial ischemia, FASEB 2003; 17: 1105-1107.
20. Martin-Du Pan RC, Ricou F. Use of brain natriuretic peptide (BNP) in the diagnosis and treatment of heart failute. Rev Med Suisse Romande 2003; 123: 125-128.
21. Selvais PL, Donckier JE, Robert A et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. Eur J Clin Invst 1998; 28: 636-642.
22. Stein BC, Levin RI. Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J 1998; 5: 916-923.
23. Kubler P, Banasiak W, Reczuch K, Ponikowski P. O BNP - nowym wskaźniku prognostycznym w ostrych zespołach wień cowych? Kardiol Pol 2003; 58: 412-414.
24. Sudah T, Minamino N, Kangawa K, Matsuo H. A new natriuretic peptide in human brain. Nature 1988; 332: 78-81.
25. Gackowski A, Isnard R, Piwowarska E, Komajda M. Peptyd natriuretyczny typu B. Nowa metoda w diagnostyce niewydolności serca. Kardiol Pol 2002; 56: 644-648.
26. Dahlsyrom U. Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur Heart Fail 2004; 6: 281-287,
27. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study. Am J Med 2004; 116: 509-516.
28. Logeart D, Gambert A, Beyne P et al. Brain natriuretic peptide (BNP) in coronary insufficiency: reletionship with left ventricular filling and exercise tolerancr. Ann Cardiol Angeiol 1999; 48: 523-528.
29. Maisel AS, McCord J, Nowak RM et al. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 2003; 41: 2010-2017.
30. Yamaguchi H, Yoshida J, Yamamoto K. Elevation of plsma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hyperttrophy. J Am Coll Cardiol 2004; 43: 55-60.
31. Mottram PM, Leano R, Marvick TH et al. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function. Am J Cardiol 2003; 92: 1434-1438.
32. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community - based study. Circulation 2004; 109: 3176-3181.
33. Troughton RW, Prior DL, Pereira JJ et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J AM Coll Cardiol 2004; 43: 416-422.
34. Celiński R, Cholewiński W, Stefaniak B, Tarkowska A. Ocena zależności miedzy steżeniem BNP w surowicy krwi a funkcja skurczowa komory lewej serca, w przypadkach choroby niedokrwiennej serca. Probl Med Nukl 2004; 18: 61 (A).
35. Valli N, Georges A, Corcuff JB, Barat JL, Bordenave L. Assessment of brain natriuretic peptide in patients with suspected hesrt failure: comparison with radionuclide ventriculography data. Clinica Chemica Acta 2001; 306: 19-26.
36. Green M, Bacharach SL. Functional imaging of the heart: Methods, limitations and examples from gated blood pool scintigraphy. Progr Cardiovasc Dis 1986; 28: 319-348.